Significant Accounting Policies - Concentration of revenue (Details) - P3 Health Partners Inc. - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 11 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 02, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Concentration Risk [Line Items] | ||||||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Successor | Successor | Predecessor | Predecessor | Successor | Predecessor | Predecessor | Predecessor | Predecessor |
| Total Revenue by Year | $ 58,762,397 | $ 269,453,971 | $ 144,586,444 | $ 542,998,305 | $ 295,884,386 | $ 578,602,418 | $ 491,063,525 | $ 145,482,112 | ||
| Revenue | Customer Concentration | ||||||||||
| Concentration Risk [Line Items] | ||||||||||
| Total Revenue by Year | $ 58,762,397 | $ 269,453,971 | $ 144,586,444 | $ 542,998,305 | $ 295,884,386 | $ 578,602,418 | $ 491,063,525 | $ 145,482,112 | ||
| Percentage of total revenue | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | ||
| Health Plan A | Revenue | Customer Concentration | ||||||||||
| Concentration Risk [Line Items] | ||||||||||
| Total Revenue by Year | $ 11,664,112 | $ 48,047,307 | $ 39,119,191 | $ 93,285,372 | $ 77,813,676 | $ 139,289,079 | $ 147,906,495 | |||
| Percentage of total revenue | 20.00% | 17.80% | 27.10% | 17.20% | 26.30% | 24.00% | 30.00% | |||
| Health Plan B | Revenue | Customer Concentration | ||||||||||
| Concentration Risk [Line Items] | ||||||||||
| Total Revenue by Year | $ 12,757,714 | $ 45,818,789 | $ 33,449,667 | $ 93,838,172 | $ 67,034,039 | $ 126,460,232 | $ 112,384,330 | $ 13,557,771 | ||
| Percentage of total revenue | 22.00% | 17.00% | 23.20% | 17.30% | 22.70% | 22.00% | 23.00% | 9.00% | ||
| Health Plan C | Revenue | Customer Concentration | ||||||||||
| Concentration Risk [Line Items] | ||||||||||
| Total Revenue by Year | $ 6,156,558 | $ 54,392,897 | $ 18,412,847 | $ 109,714,073 | $ 37,693,084 | $ 71,061,602 | $ 66,237,074 | $ 27,788,287 | ||
| Percentage of total revenue | 10.00% | 20.20% | 12.70% | 20.20% | 12.70% | 12.00% | 13.00% | 19.00% | ||
| Health Plan D | Revenue | Customer Concentration | ||||||||||
| Concentration Risk [Line Items] | ||||||||||
| Total Revenue by Year | $ 10,337,160 | $ 36,013,196 | $ 27,231,621 | $ 72,876,157 | $ 54,925,880 | $ 114,496,751 | $ 62,683,829 | $ 6,106,544 | ||
| Percentage of total revenue | 18.00% | 13.40% | 18.80% | 13.40% | 18.60% | 20.00% | 13.00% | 4.00% | ||
| All Other | Revenue | Customer Concentration | ||||||||||
| Concentration Risk [Line Items] | ||||||||||
| Total Revenue by Year | $ 13,580,241 | $ 85,181,782 | $ 26,373,118 | $ 173,284,531 | $ 58,417,707 | $ 78,111,115 | $ 25,803,950 | $ 11,903,658 | ||
| Percentage of total revenue | 23.00% | 31.60% | 18.20% | 31.90% | 19.70% | 13.00% | 5.00% | 9.00% | ||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|